human GIP(3-30), amide TFA is a high affinity antagonist of the human GIP receptor in vitro.
References:
[1]. Sparre-Ulrich AH, et al. GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release. Biochem Pharmacol. 2017;131:78-88.
















